Search

Author/Creator Udby, Lene

1. Immunological monitoring of newly diagnosed CML patients treated with bosutinib or imatinib first-line. (2nd September 2019)

Authors:
Kreutzman, Anna; Yadav, Bhagwan; Brummendorf, Tim H.; Gjertsen, Bjorn Tore; Hee Lee, Moon; Janssen, Jeroen; Kasanen, Tiina; Koskenvesa, Perttu; Lotfi, Kourosh; Markevärn, Berit; Olsson-Strömberg, Ulla; Stentoft, Jesper; Stenke, Leif; Söderlund, Stina; Udby, Lene; Richter, Johan; Hjorth-Hansen, He...
Journal:
Oncoimmunology
Issue:
Volume 8:Number 9(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Long‐term tolerability and efficacy after initial PegIFN‐α addition to dasatinib in CML‐CP: Five‐year follow‐up of the NordCML007 study. (31st August 2021)

Authors:
Flygt, Hjalmar; Söderlund, Stina; Stentoft, Jesper; Richter, Johan; Koskenvesa, Perttu; Mustjoki, Satu; Majeed, Waleed; Lübking, Anna; Dreimane, Arta; Markevärn, Berit; Stenke, Leif; Myhr Eriksson, Kristina; Gjertsen, Bjørn Tore; Gedde‐Dahl, Tobias; Dimitrijevic, Andreja; Udby, Lene; Olsson‐Ström...
Journal:
European journal of haematology
Issue:
Volume 107:Number 6(2021)
Page Start:
617
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Variant‐specific discrepancy when quantitating BCR‐ABL1 e13a2 and e14a2 transcripts using the Europe Against Cancer qPCR assay. (1st May 2019)

Authors:
Kjaer, Lasse; Skov, Vibe; Andersen, Morten T.; Aggerholm, Anni; Clair, Philippe; Gniot, Michal; Soeby, Karen; Udby, Lene; Dorff, Mikkel H.; Hasselbalch, Hans; Pallisgaard, Niels
Journal:
European journal of haematology
Issue:
Volume 103:Number 1(2019)
Page Start:
26
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗